Letters

Who should talk to patients with cancer about genetics?

BMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7078.441 (Published 08 February 1997) Cite this as: BMJ 1997;314:441
  1. Wendy Chorley, Macmillan genetic nurse specialista,
  2. Kay MacDermot, Senior lecturer in clinical geneticsa
  1. a Clinical Genetic Department, Royal Free Hospital, London NW3 2QG

    Editor–Mutations in the recently identified BRCA1, BRCA2, MLH1, and MSH2 genes are associated with high risk of developing common cancers–namely, of the breast, ovary, and colorectum.1 2 As the general public is already informed in the popular press about the increased risk of cancer it is not surprising that the demand for genetic testing is increasing.3 The organisation, staffing, and funding of specialist breast and ovarian cancer clinics is a topical issue.

    Stoll stated that oncology …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe